• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌新型免疫相关预后标志物。

A novel immune-related prognostic signature in epithelial ovarian carcinoma.

机构信息

Department of Gynecology and Obstetrics, Shanghai Key Laboratory of Gynecology Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.

出版信息

Aging (Albany NY). 2021 Apr 4;13(7):10289-10311. doi: 10.18632/aging.202792.

DOI:10.18632/aging.202792
PMID:33819196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064207/
Abstract

The immune response is associated with the progression and prognosis of epithelial ovarian cancer (EOC). However, the roles of infiltrated immune cells and immune-related genes (IRGs) in EOC have not been reported comprehensively. In the current study, the differentially expressed genes (DEGs) were filtered based on the integrated gene expression data acquired from The University of California at Santa Cruz (UCSC) Genome Browser. Then, IRGs and transcriptional factors (TFs) were screened based on the ImmPort database and Cistrome database. A total of 501 differentially expressed IRGs, and 76 TFs were detected. A TF-mediated network was constructed by univariate Cox analysis to reveal the potential regulatory mechanisms of IRGs. Next, a nine immune-based prognostic risk model using nine IRGs (PI3, CXCL10, CXCL11, LCN6, CCL17, CCL25, MIF, CX3CR1, and CSPG5) was established. Based on the risk score worked out from the signature, the EOC patients could be classified into low-risk and high-risk groups. Furthermore, the immune landscapes, elevated by the cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) algorithm and the Tumor Immune Estimation Resource (TIMER) database, effectuated different patterns in two groups. Thus, an immune-based prognostic risk model of EOC elucidates the immune status in the tumor microenvironment, and hence, could be used for prognosis.

摘要

免疫反应与上皮性卵巢癌 (EOC) 的进展和预后相关。然而,浸润性免疫细胞和免疫相关基因 (IRGs) 在 EOC 中的作用尚未得到全面报道。在本研究中,基于从加利福尼亚大学圣克鲁兹分校 (UCSC) 基因组浏览器获取的综合基因表达数据筛选差异表达基因 (DEGs)。然后,根据 ImmPort 数据库和 Cistrome 数据库筛选 IRGs 和转录因子 (TFs)。共检测到 501 个差异表达的 IRGs 和 76 个 TFs。通过单变量 Cox 分析构建 TF 介导的网络,揭示 IRGs 的潜在调控机制。接下来,使用 9 个 IRGs(PI3、CXCL10、CXCL11、LCN6、CCL17、CCL25、MIF、CX3CR1 和 CSPG5)构建了基于 9 种免疫的预后风险模型。基于该特征得出的风险评分,EOC 患者可分为低风险和高风险组。此外,通过估计相对 RNA 转录物子集的细胞类型鉴定算法 (CIBERSORT) 和肿瘤免疫估计资源 (TIMER) 数据库对免疫景观进行了分类,两组的模式不同。因此,EOC 的基于免疫的预后风险模型阐明了肿瘤微环境中的免疫状态,因此可用于预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/e4b16c356531/aging-13-202792-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/6fddac7bdb0a/aging-13-202792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/f9a7cbfd8f23/aging-13-202792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/da8aab367e35/aging-13-202792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/605a248401dd/aging-13-202792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/573cd5f02ecb/aging-13-202792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/3d3cf0eda89b/aging-13-202792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/e4b16c356531/aging-13-202792-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/6fddac7bdb0a/aging-13-202792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/f9a7cbfd8f23/aging-13-202792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/da8aab367e35/aging-13-202792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/605a248401dd/aging-13-202792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/573cd5f02ecb/aging-13-202792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/3d3cf0eda89b/aging-13-202792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/8064207/e4b16c356531/aging-13-202792-g007.jpg

相似文献

1
A novel immune-related prognostic signature in epithelial ovarian carcinoma.上皮性卵巢癌新型免疫相关预后标志物。
Aging (Albany NY). 2021 Apr 4;13(7):10289-10311. doi: 10.18632/aging.202792.
2
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.基于免疫相关长非编码 RNA 的上皮性卵巢癌预后模型。
J Ovarian Res. 2022 Jan 15;15(1):8. doi: 10.1186/s13048-021-00930-w.
3
Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.基于肿瘤免疫微环境探索的卵巢上皮癌预后标志物的鉴定。
Genomics. 2020 Nov;112(6):4827-4841. doi: 10.1016/j.ygeno.2020.08.027. Epub 2020 Sep 2.
4
Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma.乙酰化模型预测上皮性卵巢癌患者的预后,并影响免疫微环境浸润。
J Ovarian Res. 2024 Jul 19;17(1):150. doi: 10.1186/s13048-024-01449-6.
5
A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.基于肺鳞癌免疫相关基因的与患者预后和肿瘤免疫微环境相关的稳健标志物。
Int Immunopharmacol. 2020 Nov;88:106856. doi: 10.1016/j.intimp.2020.106856. Epub 2020 Aug 7.
6
Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.基于 TCGA 数据库的上皮性卵巢癌肿瘤突变负荷的多组学分析与预后评估。
Int J Med Sci. 2020 Oct 23;17(18):3200-3213. doi: 10.7150/ijms.50491. eCollection 2020.
7
A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.一种基于结肠腺癌免疫相关基因的预后模型。
Int J Med Sci. 2020 Jul 19;17(13):1879-1896. doi: 10.7150/ijms.45813. eCollection 2020.
8
Development of a prognostic signature for esophageal cancer based on nine immune related genes.基于 9 个免疫相关基因的食管癌预后标志物的开发。
BMC Cancer. 2021 Feb 4;21(1):113. doi: 10.1186/s12885-021-07813-9.
9
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.免疫基因组学鉴定预测宫颈癌患者的预后。
Int J Mol Sci. 2021 Feb 28;22(5):2442. doi: 10.3390/ijms22052442.
10
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.一种新型肝细胞癌免疫相关预后模型的开发与验证
J Transl Med. 2020 Feb 11;18(1):67. doi: 10.1186/s12967-020-02255-6.

引用本文的文献

1
The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer.综合生物信息学方法揭示 LRP1 表达在卵巢癌中的预后意义。
Int J Mol Sci. 2024 Jul 22;25(14):7996. doi: 10.3390/ijms25147996.
2
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.化疗后免疫功能的改变与卵巢癌的延迟复发有关。
Front Immunol. 2023 Jun 26;14:1204148. doi: 10.3389/fimmu.2023.1204148. eCollection 2023.
3
An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma.

本文引用的文献

1
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.用于低级别胶质瘤生存风险分层和预后的新型免疫相关基因特征
Front Genet. 2020 Apr 15;11:363. doi: 10.3389/fgene.2020.00363. eCollection 2020.
2
A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer.一个与肿瘤微环境相关的九基因标志物可预测卵巢癌的总生存期。
Aging (Albany NY). 2020 Mar 24;12(6):4879-4895. doi: 10.18632/aging.102914.
3
The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma.
一种基于细胞外基质蛋白的人工智能预测模型,用于卵巢浆液性腺癌的预后预测和免疫治疗评估。
Front Mol Biosci. 2023 Jun 14;10:1200354. doi: 10.3389/fmolb.2023.1200354. eCollection 2023.
4
Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma.肺腺癌中血管生成相关lncRNA预后模型的构建与验证
Front Genet. 2023 Mar 14;14:1083593. doi: 10.3389/fgene.2023.1083593. eCollection 2023.
5
Molecular mechanism of Wilms' tumor (Wt1) (+/-KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis.利用生物信息学分析探讨威尔姆斯瘤(WT1)(+/KTS)变体促进卵巢上皮细胞增殖和迁移的分子机制。
J Ovarian Res. 2023 Feb 24;16(1):46. doi: 10.1186/s13048-023-01124-2.
6
Protein expression profiling identifies a prognostic model for ovarian cancer.蛋白质表达谱分析鉴定出一种卵巢癌预后模型。
BMC Womens Health. 2022 Jul 15;22(1):292. doi: 10.1186/s12905-022-01876-x.
载脂蛋白 2(LCN-2)的铁负荷决定了其在肾透明细胞癌中的促肿瘤功能。
Br J Cancer. 2020 Feb;122(3):421-433. doi: 10.1038/s41416-019-0655-7. Epub 2019 Nov 27.
4
Endometriosis and risk of ovarian cancer: what do we know?子宫内膜异位症与卵巢癌风险:我们了解多少?
Arch Gynecol Obstet. 2020 Jan;301(1):1-10. doi: 10.1007/s00404-019-05358-8. Epub 2019 Nov 19.
5
Killers 2.0: NK cell therapies at the forefront of cancer control.杀手 2.0:NK 细胞疗法引领癌症控制新前沿。
J Clin Invest. 2019 Sep 3;129(9):3499-3510. doi: 10.1172/JCI129338.
6
Immunotherapy in Ovarian Cancer: Are We There Yet?卵巢癌的免疫疗法:我们成功了吗?
J Clin Oncol. 2019 Sep 20;37(27):2460-2471. doi: 10.1200/JCO.19.00508. Epub 2019 Aug 12.
7
Epithelial ovarian cancer: Evolution of management in the era of precision medicine.上皮性卵巢癌:精准医学时代的治疗进展。
CA Cancer J Clin. 2019 Jul;69(4):280-304. doi: 10.3322/caac.21559. Epub 2019 May 17.
8
Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.巨噬细胞移动抑制因子-CD74 相互作用调节黑色素瘤细胞程序性细胞死亡配体 1 的表达。
Cancer Sci. 2019 Jul;110(7):2273-2283. doi: 10.1111/cas.14038. Epub 2019 May 29.
9
Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma.免疫介质表达特征与卵巢癌预后改善相关。
Oncoimmunology. 2019 Mar 28;8(6):e1593811. doi: 10.1080/2162402X.2019.1593811. eCollection 2019.
10
Human FOXP3 Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.人类 FOXP3 调节性 T 细胞在自身免疫和癌症中的异质性和功能。
Immunity. 2019 Feb 19;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020.